Reşat Çınar

5.4k total citations · 1 hit paper
82 papers, 3.5k citations indexed

About

Reşat Çınar is a scholar working on Pharmacology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Reşat Çınar has authored 82 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pharmacology, 19 papers in Surgery and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Reşat Çınar's work include Cannabis and Cannabinoid Research (57 papers), Pancreatic function and diabetes (19 papers) and Diet, Metabolism, and Disease (15 papers). Reşat Çınar is often cited by papers focused on Cannabis and Cannabinoid Research (57 papers), Pancreatic function and diabetes (19 papers) and Diet, Metabolism, and Disease (15 papers). Reşat Çınar collaborates with scholars based in United States, Hungary and Israel. Reşat Çınar's co-authors include George Kunos, Grzegorz Godlewski, Joseph Tam, Bani Mukhopadhyay, Tony Jourdan, Jie Liu, Malliga R. Iyer, Gergő Szanda, Pál Pacher and Ken Mackie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Reşat Çınar

76 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes

2013 329 citations Tony Jourdan, Grzegorz Godlewski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reşat Çınar United States	35	1.8k	894	758	741	702	82	3.5k
Grzegorz Godlewski United States	33	2.3k 1.3×	901 1.0×	1.1k 1.5×	770 1.0×	874 1.2×	68	3.8k
Joseph Tam Israel	34	2.6k 1.4×	1.2k 1.3×	1.1k 1.5×	820 1.1×	957 1.4×	104	4.8k
Sravan K. Goparaju Japan	21	1.8k 1.0×	1.1k 1.3×	566 0.7×	671 0.9×	478 0.7×	24	3.4k
Meliha Karsak Germany	16	1.7k 0.9×	945 1.1×	325 0.4×	890 1.2×	297 0.4×	30	3.6k
Cristina Blázquez Spain	30	3.1k 1.7×	1.6k 1.8×	446 0.6×	1.5k 2.1×	917 1.3×	39	5.2k
Cristoforo Silvestri Canada	29	1.3k 0.7×	1.2k 1.4×	595 0.8×	275 0.4×	337 0.5×	68	3.0k
Fariba Oveisi United States	25	1.3k 0.7×	934 1.0×	785 1.0×	336 0.5×	527 0.8×	38	3.7k
Cristina Sánchez Spain	32	3.6k 2.0×	1.2k 1.3×	486 0.6×	1.8k 2.4×	920 1.3×	73	4.8k
Douglas Osei‐Hyiaman United States	32	3.8k 2.1×	731 0.8×	1.9k 2.5×	1.0k 1.4×	1.1k 1.5×	40	5.6k
Sergio Oddi Italy	31	1.6k 0.9×	738 0.8×	295 0.4×	838 1.1×	372 0.5×	78	2.8k

Countries citing papers authored by Reşat Çınar

Since Specialization

Citations

This map shows the geographic impact of Reşat Çınar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reşat Çınar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reşat Çınar more than expected).

Fields of papers citing papers by Reşat Çınar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reşat Çınar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reşat Çınar. The network helps show where Reşat Çınar may publish in the future.

Co-authorship network of co-authors of Reşat Çınar

This figure shows the co-authorship network connecting the top 25 collaborators of Reşat Çınar. A scholar is included among the top collaborators of Reşat Çınar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reşat Çınar. Reşat Çınar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Basu, Abhishek, Muhammad Arif, Ricardo Pineda, et al.. (2025). Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis. JCI Insight. 10(15).

Dvorácskó, Szabolcs, Luca Maccioni, Grzegorz Godlewski, et al.. (2025). Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders. Journal of Medicinal Chemistry. 68(20). 21224–21248.

Kumari, Punita, Szabolcs Dvorácskó, M.D. Enos, et al.. (2024). Structural mechanism of CB1R binding to peripheral and biased inverse agonists. Nature Communications. 15(1). 10694–10694. 4 indexed citations

Permyakova, Anna, Liad Hinden, Saja Baraghithy, et al.. (2024). Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD. Journal of the American Society of Nephrology. 35(3). 281–298. 9 indexed citations

Dvorácskó, Szabolcs, Ziyi Liu, Dechun Feng, et al.. (2023). Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome Disorders. Journal of Medicinal Chemistry. 66(17). 11985–12004. 7 indexed citations

Gunduz‐Cinar, Ozge, Emma T. Brockway, Farhana Yasmin, et al.. (2023). A cortico-amygdala neural substrate for endocannabinoid modulation of fear extinction. Neuron. 111(19). 3053–3067.e10. 26 indexed citations

Padilha, Elias Carvalho, Mengbi Yang, Pranav Shah, et al.. (2023). In vitro and in vivo pharmacokinetic characterization, chiral conversion and PBPK scaling towards human PK simulation of S-MRI-1867, a drug candidate for Hermansky-Pudlak syndrome pulmonary fibrosis. Biomedicine & Pharmacotherapy. 168. 115178–115178. 3 indexed citations

Szanda, Gergő, Tony Jourdan, Éva Wisniewski, et al.. (2023). Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3. iScience. 26(7). 107207–107207. 3 indexed citations

Iyer, Malliga R., Reşat Çınar, Nathan J. Coffey, et al.. (2022). Synthesis, Biological Evaluation, and Molecular Modeling Studies of 3,4-Diarylpyrazoline Series of Compounds as Potent, Nonbrain Penetrant Antagonists of Cannabinoid-1 (CB₁R) Receptor with Reduced Lipophilicity. Journal of Medicinal Chemistry. 65(3). 2374–2387. 13 indexed citations

10.

Liu, Ziyi, Malliga R. Iyer, Grzegorz Godlewski, et al.. (2021). Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB₁R) Antagonist. ACS Pharmacology & Translational Science. 4(3). 1175–1187. 43 indexed citations

11.

Çınar, Reşat, et al.. (2021). Targeting Endocannabinoid System in Epilepsy: For Good or for Bad. Neuroscience. 482. 172–185. 10 indexed citations

12.

Çınar, Reşat, et al.. (2020). Synthetic cannabinoids induce acute lung inflammationviacannabinoid receptor 1 activation. ERJ Open Research. 6(3). 121–2020. 23 indexed citations

13.

Park, Joshua K., Nathan J. Coffey, William A. Gahl, et al.. (2019). Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 62(2). 178–190. 17 indexed citations

14.

Udi, Shiran, Liad Hinden, Adi Drori, et al.. (2019). Dual inhibition of cannabinoid CB₁ receptor and inducible NOS attenuates obesity‐induced chronic kidney disease. British Journal of Pharmacology. 177(1). 110–127. 52 indexed citations

15.

Kale, Vijay P., Seth Gibbs, John Taylor, et al.. (2019). Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis. Regulatory Toxicology and Pharmacology. 109. 104483–104483. 21 indexed citations

16.

Benfeitas, Rui, Gholamreza Bidkhori, Bani Mukhopadhyay, et al.. (2018). Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis. EBioMedicine. 40. 471–487. 37 indexed citations

17.

Valenta, Ines, Zoltán V. Varga, Heather Valentine, et al.. (2018). Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity. JACC. Cardiovascular imaging. 11(2). 320–332. 22 indexed citations

18.

Çınar, Reşat, Bernadette R. Gochuico, Malliga R. Iyer, et al.. (2017). Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis. JCI Insight. 2(8). 68 indexed citations

19.

Çınar, Reşat, Grzegorz Godlewski, Jie Liu, et al.. (2013). Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides. Hepatology. 59(1). 143–153. 144 indexed citations

20.

Rajesh, Mohanraj, Sándor Bátkai, Malek Kechrid, et al.. (2012). Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy. Diabetes. 61(3). 716–727. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact